How and Why MSLs Bring VALUE to an Organization
In this episode, Steven Stein, senior director of global field medical at Arena Pharmaceuticals, joins the discussion to explore the evolving role of MSLs. He delves into the concept of value within the MSL role and the strategic timing for their involvement in the drug development process. Steven emphasizes early KOL engagement, overcoming internal challenges, and neutralizing negative opinions. He shares insights on enhancing KOL relationships in a hybrid environment and offers proactive strategies for MSLs. The conversation also touches on leadership, building a legacy, and future predictions for MSLs in 2022. The episode concludes with closing remarks and expressions of gratitude.
My guest today is Steven Stein, Sr. Director, Global Field Medical Head, Arena Pharmaceuticals, and we discuss how and why MSL’s bring value to an organization.
Steven shares…
👉 How early in the drug development process should MSLs be brought into a company
👉 Different ways MSL’s bring value internally to an organization
👉 How MSL’s go about enhancing medical affairs externally
👉 Ways value is tracked or measured both internally and externally
👉 Advice for MSL leaders responsible for the strategic direction of the MSL team
👉 What 2022 will look like for MSL’s and field medical
